Finn Patrick John
Finn Patrick John, PRES, reported an open-market or private sale at Twist Bioscience Corp involving 2000.000000 shares for an estimated $245162.00. Reported holdings after the transaction were 214678.000000 shares. The stored filing text includes a detected 10b5-1 reference.
- Trade date
- Aug 18, 2026
- Filing date
- Aug 20, 2026
How reported position traded is calculated
Shares sold ÷ (holdings after + shares sold). Estimated position before: 216,678 shares.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
TWST price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- Sell Code S
- Identifier
- 0001214659-26-010645 Common Stock
- Transaction date
- Aug 18, 2026 Filed Aug 20, 2026, 08:05 PM · 2d delay
- Shares
- 2,000 sh $122.58 per share
- Estimated value
- -$245k Computed from shares × price
- Holdings after
- 214,678 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
0 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - timely_filing+4 points
reporting_delay_days = 2
Filing reported within two business days of the transaction. - tenb5_1_detected-10 points
is_10b5_1 = true
Stored filing content includes detected 10b5-1 language.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
President and COO
- F1
The transactions reported on this Form 4 were affected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on May 18, 2026.
- F2
Represents the weighted average sales price per share. The shares sold at prices ranging from $115.35 to $116.33 per share. Full information regarding the number of shares sold at each price shall be…
- F3
Represents the weighted average sales price per share. The shares sold at prices ranging from $116.37 to $117.36 per share. Full information regarding the number of shares sold at each price shall be…
- F4
Represents the weighted average sales price per share. The shares sold at prices ranging from $117.37to $118.19 per share. Full information regarding the number of shares sold at each price shall be p…
- F5
Represents the weighted average sales price per share. The shares sold at prices ranging from $118.505 to $119.45 per share. Full information regarding the number of shares sold at each price shall be…
- F6
Represents the weighted average sales price per share. The shares sold at prices ranging from $119.515 to $120.2 per share. Full information regarding the number of shares sold at each price shall be…
- F7
Represents the weighted average sales price per share. The shares sold at prices ranging from $120.585 to $121.53 per share. Full information regarding the number of shares sold at each price shall be…
- F8
Represents the weighted average sales price per share. The shares sold at prices ranging from $122.00 to $122.815 per share. Full information regarding the number of shares sold at each price shall be…
- F9
The option was 100% exercisable on December 19, 2022.
0 other transactions
0 recent txs